# US 2026/0275310 A1 · Strand Displacement-Based Gene Editing Method and System and Use Thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0275310 A1
- Document ID: US20260275310A1
- Status: Published application
- Kind: A1
- Application number: 19/462,424
- Filed: 2026-01-28
- Published: 2026-09-17
- Earliest claimed: 2024-12-01
- Applicants: Beijing Qi Biodesign Biotechnology Company Limited
- Inventors: Kevin T. ZHAO; Jiacheng HU
- Web page: https://patentgrep.com/patent/US20260275310A1

## CPC

- C12N 9/222: {Clustered regularly interspaced short palindromic repeats [CRISPR]-associated [CAS] enzymes}
- C12N 5/0602: {Vertebrate cells}
- C12N 9/14: Hydrolases (3)
- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12N 15/102: {Mutagenizing nucleic acids}
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12Y 301/11001: Exodeoxyribonuclease I (3.1.11.1)
- C12Y 301/11002: Exodeoxyribonuclease III (3.1.11.2)
- C12Y 301/11003: Exodeoxyribonuclease (lambda-induced) (3.1.11.3)
- C12Y 306/04012: DNA helicase (3.6.4.12)
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12N 2510/00: Genetically modified cells
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

The present disclosure belongs to the field of genetic engineering. The present disclosure relates to a strand displacement-based gene editing method and system, and use thereof. Specifically, the present disclosure relates to a gene editing method based on strand displacement mediated by the Twinkle protein, and a gene editing system based on the strand displacement, and use thereof.

## Claims

### Claim 1

A method for performing strand displacement-based gene editing in a DNA sequence, the method comprising:
bringing a double-stranded DNA sequence into contact with a sequence-specific nucleic acid nickase to create a nick on the double-stranded DNA sequence;
digesting from the nick with an exonuclease to generate a free single-stranded DNA;
bringing the free single-stranded DNA into contact with an invader DNA and a human mitochondrial DNA helicase Twinkle enzyme; wherein the invader DNA is a single-stranded or double-stranded DNA, and at least one strand of the invader DNA comprises a glue point complementary to the free single-stranded DNA and a displacement template containing a desired nucleotide alteration;
thereby subjecting the glue point of the invader DNA to complementary pairing with the free single-stranded DNA;
thereby subjecting the displacement template of the invader DNA to a strand displacement reaction with an endogenous DNA strand adjacent to a nick site; and
performing DNA repair/replication to introduce the desired nucleotide alteration into the double-stranded DNA sequence.

### Claim 2 (depends on 1)

The method according to claim 1, wherein a process of the DNA repair comprises: (1) performing the DNA repair using the displacement template as a template to form a product with the desired nucleotide alteration on two DNA strands; and (2) repairing the nick on DNA.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the process of the DNA repair further comprises excising the endogenous DNA strand adjacent to the nick site using a structure-specific nuclease after the strand displacement reaction; wherein the structure-specific nuclease is preferably FEN1.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the sequence-specific nucleic acid nickase is a CRISPR-associated protein (Cas) polypeptide having a nickase activity, a zinc finger nuclease (ZFN), a transcription activator-like effector nuclease (TALEN), a meganuclease, a sequence-specific endonuclease, or a variant, fragment and combination thereof; or
wherein the sequence-specific nucleic acid nickase is a CRISPR-associated protein (Cas) polypeptide having a nickase activity, the Cas polypeptide is selected from Cas3, Cas4, Cas5, Cas5e, Cas6, Cas6e, Cas6f, Cas7, Cas8a1, Cas8a2, Cas8b, Cas8c, Cas9, Cas10, Cas10d, Cas12, Cas13, Cas14, CasX, CasF, CasG, CasH, Csy1, Csy2, Csy3, Cse1, Cse2, Cse3, Cse4, Csc1, Csc2, Csa5, Csn1, Csn2, Csm2, Csm3, Csm4, Csm5, Csm6, Cmr1, Cmr3, Cmr4, Cmr5, Cmr6, Cpf1, Csb1, Csb2, Csb3, Csx17, Csx14, Csx10, Csx16, CsaX, Csx3, Csz1, Csx15, Csf1, Csf2, Csf3, Csf4, Cu1966, TranC, and a variant, fragment or any combination thereof, or
wherein the sequence-specific nucleic acid nickase comprises a mutant comprising a D10A mutation or an H840A mutation corresponding to the amino acid sequence set forth in SEQ ID NO: 1.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the Twinkle enzyme is a naturally occurring or truncated Twinkle enzyme; and the Twinkle enzyme comprises a carboxyl-terminal domain (CTD) having an amino acid sequence set forth in SEQ ID NO: 2; and/or
wherein a mitochondrial localization signal is removed from the Twinkle enzyme, and then a nuclear localization signal (NLS) is fused to an amino terminus and/or carboxyl terminus of the Twinkle enzyme.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the exonuclease is a 3′ exonuclease or a 5′ exonuclease or a combination thereof; wherein the 3′ exonuclease is preferably Trex2; and the 5′ exonuclease is preferably mExol or T5 exonuclease.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the desired nucleotide alteration comprises a substitution, insertion or deletion of one or more nucleotides.

### Claim 8

A strand displacement-based gene editing system, comprising components of the strand displacement-based gene editing system and/or an expression construct comprising a nucleotide sequence that encodes the components of the strand displacement-based gene editing system, the components of the strand displacement-based gene editing system comprising:
i) a sequence-specific nucleic acid nickase or a domain thereof that is guided by a guide RNA (sgRNA) sequence to a target DNA;
ii) an exonuclease or a domain thereof;
iii) a human mitochondrial DNA helicase Twinkle enzyme or a domain thereof; and
iv) a single-stranded or double-stranded invader DNA, wherein at least one strand of the invader DNA comprises a glue point complementary to a free single-stranded DNA generated under action of a nickase and the exonuclease, and a displacement template containing a desired nucleotide alteration;
the components being independent of each other, or at least two of the components are linked via a linker to form a fusion protein.

### Claim 9 (depends on 8)

The strand displacement-based gene editing system according to claim 8, wherein the components of the strand displacement-based gene editing system further comprise:
v) a structure-specific nuclease;
wherein the structure-specific nuclease is preferably FEN1.

### Claim 10 (depends on 8)

The strand displacement-based gene editing system according to claim 8, wherein the sequence-specific nucleic acid nickase is a CRISPR-associated protein (Cas) polypeptide having a nickase activity, a zinc finger nuclease (ZFN), a transcription activator-like effector nuclease (TALEN), a meganuclease, a sequence-specific endonuclease, or a variant, fragment and combination thereof; or
wherein the sequence-specific nucleic acid nickase is the CRISPR-associated protein (Cas) polypeptide having a nickase activity; and the components of the strand displacement-based gene editing system further comprise: vi) a guide RNA that guides a corresponding Cas polypeptide to a target nucleotide region; or
wherein the sequence-specific nucleic acid nickase is the CRISPR-associated protein (Cas) polypeptide having a nickase activity; and the components of the strand displacement-based gene editing system further comprise: vi) a guide RNA that guides a corresponding Cas polypeptide to a target nucleotide region, the Cas polypeptide is selected from Cas3, Cas4, Cas5, Cas5e, Cas6, Cas6e, Cas6f, Cas7, Cas8a1, Cas8a2, Cas8b, Cas8c, Cas9, Cas10, Cas10d, Cas12, Cas13, Cas14, CasX, CasF, CasG, CasH, Csy1, Csy2, Csy3, Cse1, Cse2, Cse3, Cse4, Csc1, Csc2, Csa5, Csn1, Csn2, Csm2, Csm3, Csm4, Csm5, Csm6, Cmr1, Cmr3, Cmr4, Cmr5, Cmr6, Cpf1, Csb1, Csb2, Csb3, Csx17, Csx14, Csx10, Csx16, CsaX, Csx3, Csz1, Csx15, Csf1, Csf2, Csf3, Csf4, Cu1966, TranC, and a variant, fragment or any combination thereof, or
wherein the sequence-specific nucleic acid nickase comprises a mutant comprising a D10A mutation or an H840A mutation corresponding to the amino acid sequence set forth in SEQ ID NO: 1.

### Claim 11 (depends on 8)

The strand displacement-based gene editing system according to claim 8, wherein the Twinkle enzyme is a naturally occurring or truncated Twinkle enzyme; and the Twinkle enzyme comprises a carboxyl-terminal domain (CTD) having an amino acid sequence set forth in SEQ ID NO: 2.

### Claim 12 (depends on 8)

The strand displacement-based gene editing system according to claim 8, wherein the exonuclease is a 3′ exonuclease or a 5′ exonuclease or a combination thereof; wherein the 3′ exonuclease is preferably Trex2; and the 5′ exonuclease is preferably mExol or T5 exonuclease.

### Claim 13 (depends on 8)

The strand displacement-based gene editing system according to claim 8, wherein a nuclear localization signal (NLS) is fused to an amino or carboxyl terminus of at least one of the components; and/or
wherein the linker comprises an amino acid sequence (GGGS)n, (GGGGS)n, (G)n, (EAAAK)n, (GGS)n, (SGGS)n or SGSETPGTSESATPES, or a (XP)n motif or a combination thereof, wherein n is independently an integer of 1 to 30, and wherein X is any amino acid.

### Claim 14 (depends on 8)

The strand displacement-based gene editing system according to claim 8, wherein each of the components of the strand displacement-based gene editing system is recruited via a recruitment system that is a MCP-MS2 system or a GCN4-ScFv system.

### Claim 15 (depends on 8)

A host cell, wherein the host cell comprises the strand displacement-based gene editing system according to claim 8.

### Claim 16 (depends on 8)

A method for generating at least one cell that is genetically modified, wherein the method comprises introducing the strand displacement-based gene editing system according to claim 8 into the at least one cell to cause a substitution, insertion or deletion of one or more nucleotides within a target nucleotide editing region in the at least one cell.

### Claim 17 (depends on 16)

The method according to claim 16, wherein the method further comprises a step of screening the at least one cell for a cell having one or more desired nucleotide substitutions.

### Claim 18 (depends on 16)

The method according to claim 16, wherein the cell is derived from a prokaryote such as bacteria; or an eukaryote such as plants, fungi or vertebrates; or
wherein the cell is derived from vertebrates, the vertebrates are mammals such as human, mouse, rat, monkey, dog, pig, sheep, cattle, and cat; or
wherein the cell is derived from plants, the plants are crop plants, such as wheat, rice, corn, soybean, sunflower, sorghum, oilseed rape, alfalfa, cotton, barley, millet, sugar cane, tomato, tobacco, cassava or potato.

### Claim 19 (depends on 8)

A method for gene or genome editing, detection and/or diagnosis of a target nucleotide, editing of a target nucleotide sequence to modify an organism or a non-human organism, or treatment of a disease, wherein the method comprises utilizing the strand displacement-based gene editing system according to claim 8.

### Claim 20 (depends on 8)

A kit, wherein the kit comprises the strand displacement-based gene editing system according to claim 8.
